Projects per year
Fingerprint
Dive into the research topics where Ph.D. Program in Drug Discovery and Development Industry is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Che-Chang Chang
- The Ph.D. Program for Translational Medicine - Associate Professor
- Graduate Institute of Biomedical Informatics - Joint-Appointment Associate Professor
- International Ph.D. Program for Translational Science - Joint-Appointment Associate Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Associate Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Associate Professor
Person: Researcher
-
Hung-Ming Chang
- Department of Anatomy and Cell Biology - Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- TMU Research Center of Neuroscience - Member
Person: Academic, Researcher
-
Wei-Chiao Chang
- Department of Clinical Pharmacy - Professor
- Master Program in Applied Epidemiology - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Professor
- The Ph.D. Program for Translational Medicine - Joint-Appointment Professor
- Ph.D. Program in Medical Neuroscience - Joint-Appointment Professor
- TMU Research Center of Drug Discivery - Member
- TMU Research Center of Cancer Translational Medicine - Member
Person: Researcher
-
探討非選擇性與選擇性組蛋白去乙醯酶抑制劑與免疫檢查點抑制劑合併治療之效用及其機轉(3/3)
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討組蛋白去乙醯酶8抑制劑干擾染色質複製的藥理機轉及評估其與檢查點激酶抑制劑合併治療癌症的潛力
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
DYRK1B抑制劑於胰臟癌中之活體藥效測試
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
2, 3, 5, 4’-tetrahydroxystilbene-2-O-beta-D-glucoside protects against neuronal cell death and traumatic brain injury-induced pathophysiology
Chen, Y. H., Chen, Y. C., Chin, Y. T., Wang, C. C., Hwang, L. L., Yang, L. Y. & Lu, D. Y., 2022, In: Aging. 14, 6, p. 2607-2627 21 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrier
Sharma, R., Chatterjee, E., Mathew, J., Sharma, S., Rao, N. V., Pan, C. H., Lee, S. B., Dhingra, A., Grewal, A. S., Liou, J. P., Guru, S. K. & Nepali, K., Oct 5 2022, In: European Journal of Medicinal Chemistry. 240, 114602.Research output: Contribution to journal › Article › peer-review
-
A machine learning-driven approach for prioritizing food contact chemicals of carcinogenic concern based on complementary in silico methods
Wang, C. C., Liang, Y. C., Wang, S. S., Lin, P. & Tung, C. W., Feb 2022, In: Food and Chemical Toxicology. 160, 112802.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Datasets
-
Additional file 1 of Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer
Cheng, Y. (Contributor), Wu, T. (Contributor), Wang, Y. (Contributor), Cheng, T. (Contributor), Chen, I. (Contributor), Lu, Y. (Contributor), Chuang, K. (Contributor), Wang, C. (Contributor), Chen, C. (Contributor), Lin, R. (Contributor), Chen, H. (Contributor), Liao, T. (Contributor), Liu, E. (Contributor) & Chen, F. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.12885938.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Humanized_bispecific_antibody_mPEG_HER2_rapidly_confers_PEGylated_nanoparticles_tumor_specificity_for_multimodality_imaging_in_breast_cancer/12885938/1
Dataset
-
Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer
Cheng, Y. (Contributor), Wu, T. (Contributor), Wang, Y. (Contributor), Cheng, T. (Contributor), Chen, I. (Contributor), Lu, Y. (Contributor), Chuang, K. (Contributor), Wang, C. (Contributor), Chen, C. (Contributor), Lin, R. (Contributor), Chen, H. (Contributor), Liao, T. (Contributor), Liu, E. (Contributor) & Chen, F. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.c.5105096.v1, https://springernature.figshare.com/collections/Humanized_bispecific_antibody_mPEG_HER2_rapidly_confers_PEGylated_nanoparticles_tumor_specificity_for_multimodality_imaging_in_breast_cancer/5105096/1
Dataset
-
Additional file 1: Table S1. of Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver
Liao, Y. (Contributor), Lee, T. (Contributor), Twu, Y. (Contributor), Hsu, S. (Contributor), Yang, C. (Contributor), Wang, C. (Contributor), Liang, Y. (Contributor) & Chen, Y. (Contributor), Unknown Publisher, Oct 4 2016
DOI: 10.6084/m9.figshare.c.3614684_d1.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Glycine_N-methyltransferase_deficiency_in_female_mice_impairs_insulin_signaling_and_promotes_gluconeogenesis_by_modulating_the_PI3K_Akt_pathway_in_the_liver/4374110/1
Dataset